Western Companies Pfizer updated its public R&D pipeline on 4 November 2025, highlighting late-stage vaccine assets (including RSV, meningococcal, and next-generation COVID products) while signaling a more selective...
South Africa — Biovac (WHO mRNA hub) Sept 2025 — The Biovac Institute (South Africa) is scaling mRNA manufacturing capacity as a core partner of WHO’s mRNA Technology Transfer Programme, with roles spanning technology...